NIH To Test Single-Dose Antibiotic Azithromycin To Reduce Risk Of Maternal, Infant Sepsis In 7 LMICs
NIH: NIH to test one-dose antibiotic for the prevention of maternal and infant sepsis
“Researchers supported by the National Institutes of Health and the Bill & Melinda Gates Foundation will assess whether a single oral dose of the antibiotic azithromycin during labor reduces the risk of maternal and infant bacterial infection and death in seven low- and middle-income countries. … Maternal death from sepsis — a system-wide reaction to bacterial and other infections — is higher in many low- and middle-income countries, compared to wealthy countries. … Azithromycin, an antibiotic effective against a broad range of bacteria, has been shown to protect against infection resulting from cesarean delivery. … The current study plans to enroll up to 34,000 women at [National Institute of Child Health and Human Development (NICHD)] Global Network sites in Bangladesh, the Democratic Republic of the Congo, Guatemala, India, Kenya, Pakistan, and Zambia…” (6/3).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.